Search results
A viral blog post from a bureaucrat exposes why tech billionaires fear Biden — and fund Trump
Salon via Yahoo News· 8 hours agoRather than dial back the shady behavior, the tech industry is turning to Donald Trump, a man whose...
Boeing hid questionable parts from regulators that may have been installed in 737 Max planes, new...
CNN Business via Yahoo Finance· 6 days agoA current Boeing employee claims that the company tried to shield broken or out-of-specification 737...
Supreme Court won’t take up Georgia dispute over ‘at-large’ elections and minority vote dilution
CNN via AOL· 3 hours agoThe Supreme Court won’t take up a case challenging Georgia’s system for electing its public utility...
Federal regulators approve final rule for AVM usage - HousingWire
HousingWire· 4 days agoOn Thursday, two U.S. regulators — the Office of the Comptroller of the Currency (OCC) and the...
Citi's 'living will' flaws manageable but distracting, J.P.Morgan says
Reuters via Yahoo Finance· 4 hours ago"It adds to the list of issues that management needs to focus on," the brokerage said, noting...
AI Stocks: Tech Giants, Cloud Titans, Chipmakers Battle For An Edge
Investor's Business Daily· 3 hours agoA bellwether for AI stocks, chipmaker Nvidia's shares have jumped 155% in 2024. However, NVDA stock...
Wall Street Expects ‘Cautious’ Payouts After Bank Stress Tests
Barrons.com· 5 hours agoIf banks’ earnings offer a window into the economy’s health, then the annual results of big lenders’...
‘Time To Panic?’—Sudden $200 Billion Bitcoin, Ethereum, Solana, XRP And Crypto Price Crash Triggers...
Forbes· 12 hours agoSubscribe now to Forbes' CryptoAsset & Blockchain Advisor and "uncover blockchain blockbusters...
Morning Bid: Transatlantic split reopens as half-year nears
Reuters· 7 hours agoGlobal investors head to the half-year point this week trying to get across numerous political...
ImmunityBio Loses Bid to Dodge Investor Suit Over Drug Rejection
Bloomberg Law· 3 days agoImmunityBio Inc. must face a shareholder lawsuit alleging the biotech company misled investors about the manufacturing process for its flagship drug candidate. The suit was ...